SYRS
- Syros Pharmaceuticals, Inc.
()
Overview
Company Summary
Syros Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on developing medicines to control gene expression for the treatment of various diseases. The company utilizes its proprietary gene control platform to discover and develop potential therapeutic candidates.
Syros Pharmaceuticals' gene control platform involves identifying and targeting specific gene regulatory regions in the human genome. By understanding these regions and their role in controlling gene expression, the company aims to design innovative therapies that can modulate the activity of disease-causing genes.
The company's research primarily focuses on gene regulation in cancer and monogenic diseases. In the cancer field, Syros Pharmaceuticals aims to identify and develop drugs that can selectively reprogram cancer cells, disrupting the underlying mechanisms that drive their growth and survival. By doing so, it aims to develop improved treatment options for patients with difficult-to-treat cancers.
Syros Pharmaceuticals also explores applications of its gene control platform in monogenic diseases, which are caused by mutations in a single gene. By targeting the regulatory regions of these disease-causing genes, the company aims to develop therapies that can correct or modulate their aberrant expression, potentially providing new treatments for patients with genetic disorders.
Overall, Syros Pharmaceuticals' goal is to leverage its gene control platform to advance the understanding of gene regulation and develop innovative therapies that have the potential to improve patient outcomes across a range of diseases.